Score Overview
Explore the 2021 public Archive ranking →
Where CONMED Corporation has ranked, year by year
Showing 30 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- CNMD
2018: 49.1% · 2021: 66.4% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 46.48 | — |
1 Year2025-09-26 | $ 46.00 | 1.04% |
5 Years2021-09-28 | $ 125.58 | -62.99% |
10 Years2016-09-28 | $ 36.88 | 26.03% |
20 Years2006-09-28 | $ 17.67 | 162.99% |
30 Years1996-09-27 | $ 9.98 | 365.50% |
All Time1987-07-23 | $ 1.91 | 24x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1987-07-23 |
|---|---|---|---|---|---|---|---|
| Price | $ 46.48 | $ 46.00 | $ 125.58 | $ 36.88 | $ 17.67 | $ 9.98 | $ 1.91 |
| Return | — | 1.04% | -62.99% | 26.03% | 162.99% | 365.50% | 24x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.37B | $ 56M | $ 37M |
| 2025 | $ 1.37B | $ 47M | $ 40M |
| 2024 | $ 1.30B | $ 132M | $ 24M |
| 2023 | $ 1.24B | $ 64M | $ 24M |
| 2022 | $ 1.04B | -$ 80M | $ 28M |
| 2021 | $ 1.01B | $ 62M | $ 20M |
| 2020 | $ 862M | $ 9M | $ 27M |
| 2019 | $ 955M | $ 28M | $ 25M |
| 2018 | $ 859M | $ 40M | $ 17M |
| 2017 | $ 796M | $ 55M | $ 32M |
| 2016 | $ 763M | $ 14M | $ 27M |
| 2015 | $ 719M | $ 30M | $ 72M |
| 2014 | $ 734M | $ 32M | $ 66M |
| 2013 | $ 756M | $ 35M | $ 54M |
| 2012 | $ 767M | $ 40M | $ 23M |
| 2011 | $ 725M | $ 752K | $ 26M |
| 2010 | $ 713M | $ 30M | $ 12M |
| 2009 | $ 694M | $ 12M | $ 9M |
| 2008 | $ 742M | $ 44M | $ 11M |
| 2007 | $ 694M | $ 41M | $ 11M |
| 2006 | $ 646M | -$ 12M | $ 3M |
| 2005 | $ 617M | $ 31M | $ 3M |
| 2004 | $ 558M | $ 33M | $ 4M |
| 2003 | $ 497M | $ 32M | $ 5M |
| 2002 | $ 453M | $ 34M | $ 5M |
| 2001 | $ 428M | $ 24M | $ 1M |
| 2000 | $ 392M | $ 19M | $ 3M |
| 1999 | $ 372M | $ 27M | $ 3M |
| 1998 | $ 336M | $ 17M | $ 5M |
| 1997 | $ 138M | -$ 7M | $ 13M |
| 1996 | $ 125M | $ 16M | $ 20M |
| 1995 | $ 99M | $ 10M | $ 1M |
| 1994 | $ 71M | $ 5M | |
| 1993 | $ 53M | -$ 1M | $ 2M |
| 1992 | $ 42M | $ 4M | $ 7M |
| 1991 | $ 38M | $ 3M | $ 4M |
| 1990 | $ 31M | $ 2M | $ 200K |
| 1989 | $ 19M | -$ 300K | $ 300K |
| 1988 | $ 14M | $ 800K | $ 2M |
| IPO1987 | $ 12M | $ 1M | $ 4M |
CONMED Corporation fundamental performance
Between 2020 and 2025, revenue grew from $ 862M to $ 1.37B and net income grew from $ 9M to $ 47M. Revenue increased in 4 of those 5 years; net income in 3.
Across CONMED Corporation's full reported history, from 1987 to 2025, revenue grew from $ 12M to $ 1.37B and net income grew from $ 1M to $ 47M. Revenue increased in 85% of the years measured; net income in 51%.
CONMED Corporation currently holds a 20-year HDB Score of 4.9 out of 10. How the HDB Score is calculated.
Membership
Continue CNMD’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
